ALGS

Aligos Therapeutics, Inc. Common Stock

$5.48

-0.22 (-3.78%)

Volume:

97.461K ($534.77K)

#3584 Volume #3805 Dollar Volume

Market Capitalization:

$29.50M

#4681 Market Cap

Aligos Therapeutics Price Chart

Aligos Therapeutics Volume Chart

Aligos Therapeutics Market Segments

Regular Trading Hours

-0.34(-5.77%)

Open	$5.81
Close	$5.48
Low	$5.44
Low Change	-0.37 (-6.37%)
High	$5.88
High Change	+0.07 (+1.17%)
Range	$0.44
Volume	93.872K
Dollar Volume	$513.95K

Premarket

-0.09(-1.53%)

Open	$5.89
Close	$5.80
Low	$5.74
Low Change	-0.15 (-2.50%)
High	$5.89
High Change	+0.00 (+0.00%)
Range	$0.15
Volume	3.589K
Dollar Volume	$20.82K

After Hours Yesterday

-0.27(-4.49%)

Open	$6.01
Close	$5.74
Low	$5.74
Low Change	-0.27 (-4.49%)
High	$6.01
High Change	+0.00 (+0.00%)
Range	$0.27
Volume	3.083K
Dollar Volume	$17.70K

Regular Trading Hours Yesterday

-0.80(-12.33%)

Open	$6.49
Close	$5.69
Low	$5.68
Low Change	-0.81 (-12.48%)
High	$6.66
High Change	+0.17 (+2.62%)
Range	$0.98
Volume	164.001K
Dollar Volume	$933.17K

Premarket Yesterday

-0.24(-3.60%)

Open	$6.67
Close	$6.43
Low	$6.43
Low Change	-0.24 (-3.60%)
High	$6.70
High Change	+0.03 (+0.45%)
Range	$0.27
Volume	1.805K
Dollar Volume	$11.61K

Aligos Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$6.37
10 Day Moving Average (SMA10)	$6.36
20 Day Moving Average (SMA20)	$6.34
50 Day Moving Average (SMA50)	$6.97
100 Day Moving Average (SMA100)	$7.54
200 Day Moving Average (SMA200)	$8.44

Aligos Therapeutics Statistics

Average Volume (30 Days)	342.24K
P/E Ratio (Current)	-.46
EPS (Current)	-$14.60
Dividend Yield	0.00%
Free Cash Flow	-$85.19M
Cash Ratio	1.29
Current Ratio	2.55
Quick Ratio	2.55
Debt to Equity	0.00
Enterprise Value	$11.50M
EV to EBITDA	-0.12
EV to Sales	2.44
Price to Book	1.30
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	8.80
Return on Assets	-1.40%
Return on Equity	-2.84%

Aligos Therapeutics Stock Splits

There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.

Date	Type	Ratio
Aug 19, 2024	Reverse	25:1

Aligos Therapeutics Dividends

There have been no dividends for Aligos Therapeutics (ALGS).